A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome

• Main Authors: Zoe Wei (Author), Yasmin Gilbert (Author), Arabhi Thananjeyan (Author), James Cope (Author), Rachael L. Morton (Author), Annie Li (Author), Cecile T. Pham (Author), Meredith Ward (Author), Ju Lee Oei (Author)
• Format: Book
• Published: MDPI AG, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/children10101685; 2227-9067
• Keywords: neonatal abstinence syndrome; neonatal opioid withdrawal syndrome; clinical practice guidelines; prenatal opioid exposure; development; Pediatrics; RJ1-570
• Source: Children, Vol 10, Iss 10, p 1685 (2023)

Background: The prevalence of neonatal abstinence syndrome is increasing, but the number and quality of clinical practice guidelines available are unknown. This systematic review aimed to identify, appraise and evaluate clinical practice guidelines for neonatal abstinence syndrome. Methods: A systematic search of databases and the grey literature was conducted between 1 June and 1 July 2022. Full-text guidelines published by national or state-wide institutions were included. The recommendations from each guideline were extracted. The AGREE-II instrument was used to assess guideline quality. Sufficient-quality scores were defined as >60 and good-quality scores were >80 for each domain of AGREE-II. Results: A total of 1703 records were identified, and 22 guidelines from the United States, Australia, Canada and the United Kingdom, published between 2012 to 2021, were included. The quality scores were low, with median scores of 37/100 for stakeholder involvement, 33/100 for methodology, 34/100 for applicability and 0 for editorial independence. Scope and purpose scored 72/100, and presentation scored 85/100. Sixteen (73%) guidelines did not meet the cut-offs for clinical use. Conclusion: Many guidelines were of insufficient quality to guide clinical practice for neonatal abstinence syndrome. This emphasises the need for high-quality studies to inform clinical practice guidelines, improve care and reduce the risk of poor outcomes in these high-risk infants.